A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis

OBJECTIVE: Axial spondyloarthritis (SpA) is a chronic inflammatory disease characterized by back pain and stiffness. The objective of this study was to determine whether golimumab is superior to placebo in patients with nonradiographic axial SpA. METHODS: This phase III, double‐blind, randomized, pl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Arthritis Rheumatol
Autori principali: Sieper, J., van der Heijde, D., Dougados, M., Maksymowych, W. P., Scott, B. B., Boice, J. A., Berd, Y., Bergman, G., Curtis, S., Tzontcheva, A., Huyck, S., Weng, H. H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2015
Soggetti:
Spondyloarthritis
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4755041/
https://ncbi.nlm.nih.gov/pubmed/26139307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39257
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi